The Future of Brachytherapy is a Partnership: Myriad Medical and C4 Imaging Introduce the First Positive Signal LDR MRI Marker Both a Seed Spacer and a Marker
Decipher the Biology of Lethal Prostate Cancer—Using Urine Metabolomics Profiling to Search for Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer. Implications for Collaborative Quality Improvement
First prospective study to determine the role of daily endorectal balloon on prostate intrafraction motion management during external beam radiotherapy
Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: A sequential dose escalation pilot study
The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: More than just a prostate gland immobilization device?
The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer
